What is the purpose of pregnancy testing under the S.T.E.P.S program?

• A. To determine medication dosage
• B. To ensure the patient's health conditions
• C. To prevent fetal exposure to thalidomide
• D. To register for prescription refill eligibility

Answer: (C)

The purpose of pregnancy testing under the S.T.E.P.S program is fundamentally centered around preventing fetal exposure to thalidomide, a medication known for its severe teratogenic effects, which can cause birth defects if taken during pregnancy. This program, which stands for System for Thalidomide Education and Prescribing Safety, was developed to ensure the safe distribution of thalidomide by implementing strict guidelines, including mandatory pregnancy testing for women of childbearing age before they can start treatment.

This precaution is vital because thalidomide can have devastating consequences for a developing fetus, leading to significant health issues. By requiring pregnancy tests, the program aims to mitigate these risks, ensuring that women are not unknowingly exposed to a medication that could harm their unborn child.

The other options, while relevant to other areas of healthcare or pharmaceutical practices, do not accurately represent the primary aim of the S.T.E.P.S program regarding pregnancy testing. For instance, determining medication dosage, ensuring patient health conditions, and managing prescription refill eligibility are all important aspects of patient care but do not address the specific safety concerns related to thalidomide exposure during pregnancy.